Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15Ink4B transcription in response to TGF‐β

Transforming growth factor‐β (TGF‐β) arrests growth of epithelial cells by inducing the transcription of p15Ink4B, a cyclin‐dependent kinase inhibitor. In this study, we demonstrate that p15Ink4B induction was mediated by a TGF‐β‐induced complex of Smad2, Smad3, Smad4 and Sp1. Mutations in the Sp1‐ or Smad‐binding sequences decreased or abolished the TGF‐β responsiveness of the p15Ink4B promoter. Interference with, or deficiency in, Smad2, Smad3 or Smad4 functions also reduced or abolished the TGF‐β‐dependent p15Ink4B induction, whereas the absence of Sp1 reduced the basal and TGF‐β‐induced p15Ink4B transcription. In the nucleoprotein complex, Smad2 interacted through its C‐domain with Sp1 and enhanced the DNA binding and transcriptional activity of Sp1. Smad3 interacted indirectly with Sp1 through its association with Smad2 and/or Smad4, and bound directly to the p15Ink4B promoter. Finally, Smad4 interacted through its N‐domain with Sp1. Our data demonstrate the physical interactions and functional cooperativity of Sp1 with a complex of Smad2, Smad3 and Smad4 in the induction of the p15Ink4B gene. These findings explain the tumor suppressor roles of Smad2 and Smad4 in growth arrest signaling by TGF‐β

[1]  D. Bigner,et al.  Transforming Growth Factor-β-mediated p15INK4BInduction and Growth Inhibition in Astrocytes Is SMAD3-dependent and a Pathway Prominently Altered in Human Glioma Cell Lines* , 1999, The Journal of Biological Chemistry.

[2]  J. Massagué,et al.  Myc Downregulation by Transforming Growth Factor β Required for Activation of the p15Ink4b G1 Arrest Pathway , 1999, Molecular and Cellular Biology.

[3]  R. Tjian,et al.  Purification of transcription cofactor complex CRSP. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[4]  James M. Roberts,et al.  CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.

[5]  W. Wang,et al.  Cooperative Binding of Smad Proteins to Two Adjacent DNA Elements in the Plasminogen Activator Inhibitor-1 Promoter Mediates Transforming Growth Factor β-induced Smad-dependent Transcriptional Activation* , 1999, The Journal of Biological Chemistry.

[6]  K. Miyazono,et al.  Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. , 1999, Science.

[7]  Robert Tjian,et al.  The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1 , 1999, Nature.

[8]  K. Miyazono,et al.  Drosophila dSmad2 and Atr‐I transmit activin/TGFβ signals , 1999, Genes to cells : devoted to molecular & cellular mechanisms.

[9]  E. Lai,et al.  FAST-2 Is a Mammalian Winged-Helix Protein Which Mediates Transforming Growth Factor β Signals , 1999, Molecular and Cellular Biology.

[10]  R. Derynck,et al.  Transcriptional Activators of TGF-β Responses: Smads , 1998, Cell.

[11]  S. Friedman,et al.  Transcriptional activation of transforming growth factor beta1 and its receptors by the Kruppel-like factor Zf9/core promoter-binding protein and Sp1. Potential mechanisms for autocrine fibrogenesis in response to injury. , 1998, The Journal of biological chemistry.

[12]  S. Friedman,et al.  Transcriptional Activation of Transforming Growth Factor β1 and Its Receptors by the Kruppel-like Factor Zf9/Core Promoter-binding Protein and Sp1 , 1998, The Journal of Biological Chemistry.

[13]  A. Roberts,et al.  SMAD3/4-dependent transcriptional activation of the human type VII collagen gene (COL7A1) promoter by transforming growth factor beta. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Xing Shen,et al.  TGF-beta-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein. , 1998, Molecular biology of the cell.

[15]  T. Gelehrter,et al.  Smad4/DPC4 and Smad3 Mediate Transforming Growth Factor-β (TGF-β) Signaling through Direct Binding to a Novel TGF-β-responsive Element in the Human Plasminogen Activator Inhibitor-1 Promoter* , 1998, The Journal of Biological Chemistry.

[16]  H. Lodish,et al.  Synergistic cooperation of TFE3 and smad proteins in TGF-beta-induced transcription of the plasminogen activator inhibitor-1 gene. , 1998, Genes & development.

[17]  J. Graff,et al.  Smad3 Mutant Mice Develop Metastatic Colorectal Cancer , 1998, Cell.

[18]  J. Massagué,et al.  Physical and Functional Interaction of SMADs and p300/CBP* , 1998, The Journal of Biological Chemistry.

[19]  Yigong Shi,et al.  Crystal Structure of a Smad MH1 Domain Bound to DNA Insights on DNA Binding in TGF-β Signaling , 1998, Cell.

[20]  K. Miyazono,et al.  Role of p300, a transcriptional coactivator, in signalling of TGF‐β , 1998, Genes to cells : devoted to molecular & cellular mechanisms.

[21]  R. Derynck,et al.  Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription , 1998, Nature.

[22]  M. Whitman Smads and early developmental signaling by the TGFbeta superfamily. , 1998, Genes & development.

[23]  C. Heldin,et al.  Identification and Functional Characterization of a Smad Binding Element (SBE) in the JunB Promoter That Acts as a Transforming Growth Factor-β, Activin, and Bone Morphogenetic Protein-inducible Enhancer* , 1998, The Journal of Biological Chemistry.

[24]  J. D. Brown,et al.  CREB binding protein is a required coactivator for Smad-dependent, transforming growth factor beta transcriptional responses in endothelial cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  K. Miyazono,et al.  Interplay of signal mediators of decapentaplegic (Dpp): molecular characterization of mothers against dpp, Medea, and daughters against dpp. , 1998, Molecular biology of the cell.

[26]  R. Derynck,et al.  The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation. , 1998, Genes & development.

[27]  Takeshi Imamura,et al.  Smad proteins exist as monomers in vivo and undergo homo‐ and hetero‐oligomerization upon activation by serine/threonine kinase receptors , 1998, The EMBO journal.

[28]  T. Hunter,et al.  TGF-beta-stimulated cooperation of smad proteins with the coactivators CBP/p300. , 1998, Genes & development.

[29]  K. Kinzler,et al.  Characterization of human FAST-1, a TGFβ and activin signal transducer , 1998 .

[30]  P. Hoodless,et al.  Smad2 and Smad3 positively and negatively regulate TGF beta-dependent transcription through the forkhead DNA-binding protein FAST2. , 1998, Molecular cell.

[31]  A. Moustakas,et al.  Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Denis Vivien,et al.  Direct binding of Smad3 and Smad4 to critical TGFβ‐inducible elements in the promoter of human plasminogen activator inhibitor‐type 1 gene , 1998, The EMBO journal.

[33]  P. P. Hu,et al.  Molecular Mechanisms of Transforming Growth Factor-β Signaling , 1998 .

[34]  J. Hudson,et al.  The Drosophila Medea gene is required downstream of dpp and encodes a functional homolog of human Smad4. , 1998, Development.

[35]  R. W. Padgett,et al.  The Drosophila gene Medea demonstrates the requirement for different classes of Smads in dpp signaling. , 1998, Development.

[36]  L. Dobens,et al.  Medea is a Drosophila Smad4 homolog that is differentially required to potentiate DPP responses. , 1998, Development.

[37]  J. Wrana,et al.  Mads and Smads in TGFβ signalling , 1998 .

[38]  R. White,et al.  Tumor Suppressing Pathways , 1998, Cell.

[39]  K. Kinzler,et al.  Human Smad3 and Smad4 are sequence-specific transcription activators. , 1998, Molecular cell.

[40]  A. Roberts Molecular and Cell Biology of TGF-β , 1998, Mineral and Electrolyte Metabolism.

[41]  Kohei Miyazono,et al.  TGF-β signalling from cell membrane to nucleus through SMAD proteins , 1997, Nature.

[42]  J. Massagué,et al.  Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes. , 1997, Genes & development.

[43]  Jeffrey L. Wrana,et al.  TβRI Phosphorylation of Smad2 on Ser465 and Ser467 Is Required for Smad2-Smad4 Complex Formation and Signaling* , 1997, The Journal of Biological Chemistry.

[44]  C. Wernstedt,et al.  Phosphorylation of Ser465 and Ser467 in the C Terminus of Smad2 Mediates Interaction with Smad4 and Is Required for Transforming Growth Factor-β Signaling* , 1997, The Journal of Biological Chemistry.

[45]  R. Derynck,et al.  TGF- receptor signaling , 1997 .

[46]  Minoru Watanabe,et al.  Smad4 and FAST-1 in the assembly of activin-responsive factor , 1997, Nature.

[47]  Takeshi Imamura,et al.  TGF‐β receptor‐mediated signalling through Smad2, Smad3 and Smad4 , 1997 .

[48]  Wei Hu,et al.  Sp1 Is Required for the Early Response of α2(I) Collagen to Transforming Growth Factor-β1* , 1997, The Journal of Biological Chemistry.

[49]  Kirby D. Johnson,et al.  Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic , 1997, Nature.

[50]  J. Massagué,et al.  Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4 , 1997, Nature.

[51]  Yigong Shi,et al.  A structural basis for mutational inactivation of the tumour suppressor Smad4 , 1997, Nature.

[52]  K. Kinzler,et al.  Frequency of Smad gene mutations in human cancers. , 1997, Cancer research.

[53]  T. Musci,et al.  The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function , 1997, Current Biology.

[54]  P. P. Hu,et al.  The viral oncoprotein E1A blocks transforming growth factor beta-mediated induction of p21/WAF1/Cip1 and p15/INK4B , 1997, Molecular and cellular biology.

[55]  J. Massagué,et al.  The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2. , 1997, Genes & development.

[56]  P. Hoodless,et al.  MADR2 Is a Substrate of the TGFβ Receptor and Its Phosphorylation Is Required for Nuclear Accumulation and Signaling , 1996, Cell.

[57]  M. Centrella,et al.  Cloning, characterization, and expression of the transforming growth factor‐β type I receptor promoter in fetal rat bone cells , 1996, Journal of cellular biochemistry.

[58]  J. Massagué,et al.  Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways , 1996, Nature.

[59]  Xin Chen,et al.  A transcriptional partner for MAD proteins in TGF-β signalling , 1996, Nature.

[60]  S. Kern,et al.  Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. , 1996, Cancer research.

[61]  R. Derynck,et al.  Receptor-associated Mad homologues synergize as effectors of the TGF-β response , 1996, Nature.

[62]  Irene L Andrulis,et al.  MADR2 Maps to 18q21 and Encodes a TGFβ–Regulated MAD–Related Protein That Is Functionally Mutated in Colorectal Carcinoma , 1996, Cell.

[63]  A. Fine,et al.  Structure and expression of the promoter for the R4/ALK5 human type I transforming growth factor-β receptor: regulation by TGF-β , 1996 .

[64]  J. Massagué,et al.  A human Mad protein acting as a BMP-regulated transcriptional activator , 1996, Nature.

[65]  Kathleen R. Cho,et al.  DPC4 gene in various tumor types. , 1996, Cancer research.

[66]  R. Derynck,et al.  Ligand-independent Activation of Transforming Growth Factor (TGF) β Signaling Pathways by Heteromeric Cytoplasmic Domains of TGF-β Receptors* , 1996, The Journal of Biological Chemistry.

[67]  C. Moskaluk,et al.  Homozygous deletion map at 18q21.1 in pancreatic cancer. , 1996, Cancer research.

[68]  Scott E. Kern,et al.  DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.

[69]  M. Sporn,et al.  Characterization of the Promoter Region of the Human Transforming Growth Factor-β Type II Receptor Gene * , 1995, The Journal of Biological Chemistry.

[70]  Jian-ming Li,et al.  Transforming Growth Factor β Activates the Promoter of Cyclin-dependent Kinase Inhibitor p15INK4B through an Sp1 Consensus Site (*) , 1995, The Journal of Biological Chemistry.

[71]  R. Derynck,et al.  Transforming Growth Factor-β (TGF-β)-induced Down-regulation of Cyclin A Expression Requires a Functional TGF-β Receptor Complex , 1995, The Journal of Biological Chemistry.

[72]  A. Iavarone,et al.  Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. , 1995, Genes & development.

[73]  Xiao-Fan Wang,et al.  Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[74]  J. Little,et al.  Potential Role of WAF1/Cip1/p21 as a Mediator of TGF-β Cytoinhibitory Effect (*) , 1995, The Journal of Biological Chemistry.

[75]  A. Fine,et al.  Structure and Expression of the Promoter for the Human Type II Transforming Growth Factor-β Receptor , 1994 .

[76]  Gregory J. Hannon,et al.  pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest , 1994, Nature.

[77]  Jeffrey L. Wrana,et al.  Mechanism of activation of the TGF-β receptor , 1994, Nature.

[78]  M. Sporn,et al.  Regulation of the transforming growth factor-β1 and -β3 promoters by transcription factor Spl , 1993 .

[79]  J. Massagué,et al.  Concomitant loss of transforming growth factor (TGF)-beta receptor types I and II in TGF-beta-resistant cell mutants implicates both receptor types in signal transduction. , 1990, The Journal of biological chemistry.

[80]  R. Derynck,et al.  Human Transforming Growth Factor- β3: Recombinant Expression, Purification, and Biological Activities in Comparison with Transforming Growth Factors-β 1 and -β2 , 1989 .

[81]  M. Sporn,et al.  Characterization of the promoter region of the human transforming growth factor-beta 1 gene. , 1989, The Journal of biological chemistry.

[82]  R. Tjian,et al.  Analysis of Sp1 in vivo reveals mutiple transcriptional domains, including a novel glutamine-rich activation motif , 1988, Cell.

[83]  M. Sporn,et al.  Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells. , 1988, The Journal of biological chemistry.

[84]  J. Wrana,et al.  The Drosophila activin receptor baboon signals through dSmad2 and controls cell proliferation but not patterning during larval development. , 1999, Genes & development.

[85]  J. Massagué TGF-beta signal transduction. , 1998, Annual review of biochemistry.

[86]  R. Derynck,et al.  Smads: transcriptional activators of TGF-beta responses. , 1998, Cell.

[87]  J. Waxman Molecular endocrinology of cancer , 1996 .

[88]  한평림 A Transcriptional Partner for MAD Proteins in TGF - b Signalling , 1996 .

[89]  M. Sporn,et al.  Transforming growth factor-beta s in mammary tumorigenesis: promoters or antipromoters? , 1995, Progress in clinical and biological research.

[90]  R. Derynck,et al.  Transforming growth factor-beta (TGF-beta)-induced down-regulation of cyclin A expression requires a functional TGF-beta receptor complex. Characterization of chimeric and truncated type I and type II receptors. , 1995, The Journal of biological chemistry.

[91]  M. Sporn,et al.  Molecular cloning and structure of the human transforming growth factor-beta 2 gene promoter. , 1991, Growth factors.

[92]  R. Tjian,et al.  Multiple specific contacts between a mammalian transcription factor and its cognate promoters , 1984, Nature.